Medicxi Ventures Management (Jersey) Ltd
ST. HELIER, Y9 · CIK 1715579 · 13F filing filed 2026-08-04
Exempt reporting adviser since 2016 · corporation
- Private funds6 · $2.4bn gross assets
- Websitemedicxi.com
- Form ADV · 2026-02-26SEC adviser record
As an employer
- Offices in2 countries
- Private fundsventure capital 6
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| St. Helier (main office)Jersey | |
| LondonUnited Kingdom | 3 |
$177.4m
reported value
-81.9% vs Q1 2026
3positions
100.0%in top 10
0 new
0 added
1 reduced
1 sold out
vs Q1 2026
This report includes the holdings of 1 other manager that shares the investment decisions:
- De Rubertis Francesco – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PHATHOM PHARMACEUTICALS INC PHAT | $81.0m45.65% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $74.9m42.19% | Reduced -465.5k |
| AURA BIOSCIENCES INC AURA | $21.6m12.16% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | $792.9m20.0m shares |